Diagnosing Primary Hyperparathyroidism

Initial Diagnostic Steps

• The American College of Endocrinology recommends measuring serum calcium (total calcium corrected for albumin) and intact parathyroid hormone (iPTH) simultaneously to diagnose primary hyperparathyroidism, with the hallmark finding being hypercalcemia or high-normal calcium with elevated or inappropriately normal PTH levels 1
• Serum phosphate is typically low or low-normal in primary hyperparathyroidism, according to the Endocrine Society 2
• Assessing vitamin D status (25-hydroxyvitamin D) is crucial as vitamin D deficiency can complicate interpretation of PTH levels, as suggested by the American College of Endocrinology 1
• Measuring serum creatinine to evaluate kidney function is essential in diagnosing primary hyperparathyroidism, as recommended by the American Urological Association 3, 4
• Checking serum chloride and uric acid levels may suggest underlying conditions associated with stone disease, according to the American Urological Association 3

Confirmatory Testing

• A 24-hour urine collection for calcium, oxalate, uric acid, citrate, sodium, potassium, and creatinine can help evaluate complications and other metabolic abnormalities in primary hyperparathyroidism, as recommended by the American Urological Association 3, 4

Differential Diagnosis Considerations

• Secondary hyperparathyroidism is characterized by normal or low serum calcium with elevated PTH, commonly seen in chronic kidney disease or vitamin D deficiency, according to the American College of Endocrinology 1
• Tertiary hyperparathyroidism is marked by hypercalcemia with elevated PTH, typically in end-stage renal disease, as described by the American College of Endocrinology 1

Imaging Studies (After Biochemical Diagnosis)

• Ultrasound of the neck is recommended as the first-line localization study for primary hyperparathyroidism, as suggested by the American College of Endocrinology 1
• Dual-phase 99mTc-sestamibi scintigraphy with SPECT/CT provides high sensitivity for localizing parathyroid adenomas, according to the American College of Endocrinology 1
• The combination of ultrasound and sestamibi scan offers the highest sensitivity for localization, as recommended by the American College of Endocrinology 1
• MRI or CT scan may be considered if initial imaging is negative, as suggested by the American College of Endocrinology 1

Special Considerations

• In patients with suspected primary hyperparathyroidism, seeking advice from a specialist with expertise in this condition is recommended, according to the World Health Organization 5
• For patients with multiple endocrine neoplasia (MEN) syndromes, screening for primary hyperparathyroidism should begin at age 11 for high-risk variants and age 16 for moderate-risk variants, as recommended by the American College of Endocrinology 1

Common Pitfalls to Avoid

• Not assessing vitamin D status when interpreting PTH levels can lead to misdiagnosis, as warned by the American College of Endocrinology 1
• Using different PTH assay generations without considering their varying sensitivity to PTH fragments can result in inaccurate diagnoses, according to the Endocrine Society 2, 1

Diagnosing Primary Hyperparathyroidism with Biochemical Tests

Essential Diagnostic Considerations

• Assessing vitamin D status (25-hydroxyvitamin D) is crucial as vitamin D deficiency can complicate interpretation of PTH levels, according to the Obesity Reviews 6
• Use assay-specific reference values for PTH measurement, as different assay generations can affect clinical interpretation, as noted by Endocrine Reviews 7
• Be aware that PTH assays differ in the antibodies used and consequently measure different PTH fragments and isoforms in addition to biologically active PTH, as discussed in Endocrine Reviews 8 and further emphasized in another Endocrine Reviews article 9
• Standardization of PTH assays is ongoing, and lack of standardization leads to significant differences in PTH concentrations measured in different laboratories, a point highlighted in Endocrine Reviews 8
• Collecting blood samples in EDTA tubes for PTH measurement is recommended as PTH is most stable in EDTA plasma, as advised by Endocrine Reviews 7
• Considering factors that influence PTH levels such as race, age, BMI, and vitamin D status is important when interpreting results, as suggested by Endocrine Reviews 7
• Not measuring vitamin D status when interpreting PTH levels can lead to misdiagnosis, a concern also raised by Obesity Reviews 6
• Biotin supplements can interfere with PTH assays and lead to under or overestimation depending on the assay design, a consideration pointed out by Endocrine Reviews 7

Diagnostic Approach to Primary Hyperparathyroidism

Laboratory Evaluation and Diagnostic Considerations

• The Endocrine Society recommends using assay-specific reference values for PTH measurement, as different assay generations can affect clinical interpretation 10
• For patients with chronic kidney disease, different diagnostic criteria apply, and imaging prior to parathyroidectomy is essential, as suggested by the National Kidney Foundation 11
• In cases of chronic kidney disease, the American Journal of Kidney Diseases guidelines suggest that imaging prior to parathyroidectomy is crucial, highlighting the importance of careful evaluation 12

Imaging Studies

• The American College of Radiology recommends that for reoperative cases or suspected ectopic glands, 4D-CT or MRI may be particularly useful 13

24-Hour Urine Calcium Interpretation in Primary Hyperparathyroidism

Primary Clinical Uses

• Patients with primary hyperparathyroidism and 24-hour urine calcium >400 mg/day are at increased risk for kidney stone formation and bone complications, according to Endocrine Reviews 14
• In patients with primary hyperparathyroidism, a 24-hour urine calcium level >400 mg/day identifies patients at increased risk for kidney stone formation and bone complications, and is a surgical indication for parathyroidectomy, as noted by Endocrine Reviews 14

Expected Findings in PHPT

• Most primary hyperparathyroidism patients demonstrate hypercalciuria (>4 mg/kg/day or >250-300 mg/day) due to increased filtered calcium load from hypercalcemia, as reported by Endocrine Reviews 14

Clinical Interpretation Algorithm

• Patients with 24-hour urine calcium >400 mg/day should be counseled about increased kidney stone risk, as indicated by Endocrine Reviews 14
• In primary hyperparathyroidism patients with 24-hour urine calcium levels between 100-400 mg/day, surgery may be considered based on other established criteria, such as age ≥50, osteoporosis, impaired kidney function, or kidney stones, according to Endocrine Reviews 14

Important Caveats and Pitfalls

• Vitamin D deficiency can suppress urine calcium excretion in primary hyperparathyroidism patients, potentially masking hypercalciuria, as noted by Endocrine Reviews 14

Diagnostic Approach to Hyperparathyroidism

Initial Biochemical Testing and Technical Considerations

• The Endocrine Society recommends using assay-specific reference ranges when interpreting PTH results, as different assay generations measure different PTH fragments and can yield significantly different values, with a lack of standardization between PTH assays leading to remarkable differences in measured concentrations between laboratories 15

Diagnostic Algorithm and Special Considerations

• The American Journal of Kidney Diseases suggests that in patients with CKD and GFR <60 mL/min/1.73 m², measuring calcium, phosphorus, and intact PTH regularly can help monitor for secondary hyperparathyroidism, and when serum intact PTH levels are between 100 and 500 pg/mL, bone biopsy may be useful if unexplained hypercalcemia, bone pain, or increased bone alkaline phosphatase develops 16

Imaging Studies and Localization

• The Journal of the American College of Radiology states that imaging has no utility in confirming or excluding the diagnosis of hyperparathyroidism, but is used only for localization after biochemical diagnosis is established, and recommends obtaining localization imaging when surgery is planned, with ultrasound of the neck as the first-line localization study 17

Diagnostic Criteria for Primary Hyperparathyroidism

Biochemical Diagnostic Essentials

• The Endocrine Society recommends that the combination of hypercalcemia with elevated or inappropriately normal parathyroid hormone (PTH) levels is characteristic of primary hyperparathyroidism 18

Evaluation of PTH Levels

• PTH levels increase with age due to decreased glomerular filtration rate 18
• PTH levels are 20% lower in individuals with sufficient vitamin D compared to those with unknown vitamin D status 18
• Elevated body mass index (BMI) increases PTH levels 18
• Race affects PTH levels, with higher levels found in black individuals 18

Considerations for Surgery

• The Endocrine Society recommends surgery for symptomatic patients 18
• Surgery is also recommended for patients with osteoporosis 18
• Patients with impaired renal function (eGFR <60 mL/min/1.73 m²) should be considered for surgery 18
• The presence of kidney stones is an indication for surgery 18
• Age ≥50 years is a consideration for surgery 18
• Calcium levels >0.25 mmol/L above the upper limit of normal are an indication for surgery 18

Primary Hyperparathyroidism Diagnosis and Management

Diagnostic Considerations

• Patients with normocalcemic primary hyperparathyroidism remain at risk for developing complications associated with classic primary hyperparathyroidism, according to the Endocrine Society 19

Laboratory Testing

• Sample collection for PTH measurement should use EDTA plasma rather than serum, as PTH is most stable in EDTA plasma, and storage at 4°C is preferred over room temperature, as stated in Endocrine Reviews 19
• PTH concentrations are higher in central blood than peripheral blood, and timing of sampling should consider the circadian rhythm of PTH, although optimal sampling time is not definitively established, as noted in Endocrine Reviews 19

Guidelines for Parathyroid Hormone Assessment in Chronic Kidney Disease

Indications for Initial PTH Measurement

• In patients with chronic kidney disease, parathyroid hormone (PTH) should be measured when the estimated glomerular filtration rate (eGFR) falls below 60 mL/min/1.73 m² (CKD stage 3 or higher); the testing frequency is then adjusted according to CKD stage and whether treatment has been started. 20
• At the same time, serum calcium and phosphorus should be measured to screen for secondary hyperparathyroidism, because PTH concentrations begin to rise at the eGFR < 60 mL/min/1.73 m² threshold and bone disease may already be present. 20, 21
• PTH measurement is also indicated when a patient presents with unexplained bone pain, pathological fractures, or kidney stones, to evaluate for underlying hyperparathyroidism. 20

Monitoring Frequency

• The overall frequency of PTH monitoring should increase as kidney function declines, reflecting the progressive risk of mineral‑bone disorder in advanced CKD. 20
• Patients whose PTH values are at the low end of the recommended target range may be monitored less often than those with higher values. 20

Assay‑Related Considerations

• Second‑generation “intact PTH” assays (the current standard) detect both biologically active PTH and inactive fragments; in CKD the inactive fragments accumulate and can cause an overestimation of true PTH activity. 21

Interpretation of PTH Values in Advanced CKD (Stage 5)

• In CKD stage 5, a PTH level between 100 pg/mL and 500 pg/mL lacks sufficient sensitivity to differentiate adynamic bone disease from high‑turnover hyperparathyroidism. 20, 22
• When a CKD stage 5 patient with PTH in this intermediate range develops any of the following, a bone biopsy should be considered:

Kidney Transplant Recipients

• After kidney transplantation, calcium, phosphorus, and PTH should be monitored more frequently according to transplant‑specific protocols, because tertiary hyperparathyroidism can persist and affect graft outcomes. 20